Severe allograft dysfunction after OKT3-induced human herpes virus-6 reactivation.
Jacobs
U
U
Medical Department, University Hospital, Rheinische Friedrich-Wilhelms-Universität Bonn, Germany.
Ferber
J
J
Klehr
H U
HU
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000628:therapy*; D006566:Herpesviridae Infections / Q000503:physiopathology*; D015654:Herpesvirus 6, Human / Q000254:growth & development; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D016853:Muromonab-CD3 / Q000009:adverse effects* / Q000627:therapeutic use; D014184:Transplantation, Homologous; D014775:Virus Activation
D000305:Adrenal Cortex Hormones; D000961:Antilymphocyte Serum; D016853:Muromonab-CD3; D016572:Cyclosporine